Abstract
Возможности «молекулярной биопсии» в дифференциальной диагностике форм легочной артериальной гипертензии: описание случая и обзор литературы
Highlights
Precision studies of pulmonary arterial hypertension (PAH) have led to identification of the subgroup of pulmonary venoocclusive disease (PVOD)
Taking into consideration the genetic data, the diagnosis in this case was changed from idiopathic PAH to PVOD
We found a variant of a nucleotide sequence, which was previously described in patients with PVOD, in exon 21 of the EIF2AK4 c.C2965T gene in the heterozygous state
Summary
Possibilities of molecular biopsy in differential diagnosis of pulmonary arterial hypertension: case description and literature review. Возможности «молекулярной биопсии» в дифференциальной диагностике форм легочной артериальной гипертензии: описание случая и обзор литературы. The article describes the clinical case of the hereditary form of PAH in a 53-year-old woman. Taking into consideration the genetic data, the diagnosis in this case was changed from idiopathic PAH to PVOD. Implementation of molecular genetic methods in routine clinical examination of patients with PAH can greatly improve and speed up the diagnostic process. Исследование патогенетических аспектов развития легочной артериальной гипертензии (ЛАГ) привело к выделению в рамках первой группы заболеваний дополнительной подгруппы – 1’ – веноокклюзионная болезнь легких (ВБЛ). Представлено описание клинического случая семейной формы ЛАГ у пациентки 53 лет. A. POSSIBILITIES OF MOLECULAR BIOPSY IN DIFFERENTIAL DIAGNOSIS OF PULMONARY ARTERIAL HYPERTENSION: CASE DESCRIPTION AND LITERATURE REVIEW.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
